Pfizer is Projected to Double Revenue in 2021

Oct 11, 2021
Vaccine

Pfizer, the world’s third largest pharmaceutical company based on prescription drug sales, is receiving a massive injection of revenue from its COVID-19 vaccine.


Pfizer projects that revenue will almost double in 2021 compared to 2020. BNT162b2, as Pfizer’s vaccine is officially called, is expected to account for more than 40% of Pfizer’s revenue for the year, dwarfing any other drug in its vast portfolio.

Pfizer revenue

Womack Investment Advisers, Inc. (WIA) is a registered investment adviser whose principal office is located in Oklahoma. Womack Investment Advisers, Inc. is also registered in the State of California, the State of Illinois, the State of Indiana, and the State of Texas. WIA only transacts business in sates where it is properly registered, or excluded, or exempted from registration requirements.

Share by: